STVN — Stevanato Group S.p.A.

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 1849853 · Italy
Last close
$15.25
Market Cap
$759.94M
52W High
$23.92
52W Low
$12.05
ADV30
979,981
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 326,063,000 94,958,000 60,325,000 41,843,000 2,667,694,000 114,902,000 1,073,694,000
Jun 2026 302,003,000 86,811,000 51,282,000 22,958,000 2,618,744,000 78,639,000 1,068,905,000
Mar 2026 273,600,000 75,200,000 38,800,000 28,000,000 2,583,821,000 111,670,000 1,052,995,000
Dec 2025 346,482,000 106,899,000 70,084,000 47,555,000 2,543,974,000 130,603,000 1,057,453,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$259,095,000
Investing CF
$-261,050,000
Financing CF
$689,000
CapEx
$-267,303,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$0.50
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$1,071,651,000
Inventory
$301,554,000
Receivables
$540,696,000
ST Investments
$716,000
EBIT TTM
$208,115,000
Pretax Income TTM
$202,679,000
Interest Exp TTM
$5,436,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,225,227,008
EBITDA
$298,831,008
Free Cash Flow
$-104,701,248
Enterprise Value
$6,074,530,304
Total Cash
$79,142,000
Total Debt
$445,302,016
Shares Out
49,832,201
Trailing EPS
$0.57
Book Value
$6.60
ROE
9.1%
ROA
5.4%
Div Yield
0.29%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,186,282,000 198,801,000 139,839,000 2,543,974,000 1,057,453,000 1,486,483,000 286,077,000
Dec 2024 1,104,036,000 161,142,000 117,778,000 2,328,819,000 924,434,000 1,404,339,000 155,776,000
Dec 2023 1,085,354,000 200,720,000 145,631,000 2,071,577,000 938,931,000 1,132,531,000 105,210,000
Dec 2022 983,680,000 192,431,000 142,849,000 1,659,698,000 663,788,000 996,130,000 103,312,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.85

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $10.00 · spot: $15.36 · call volume: 19 · put volume: 11
Expected Move to 2027-03-19: ±$3.98 (25.88%) — implied range $11.38 – $19.33 · ATM straddle on $15.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
INMD InMode Ltd. $743.47M $12.92 —
BVS Bioventus Inc. $725.83M $10.60 —
BBNX Beta Bionics, Inc. $800.28M $14.72 —
KIDS ORTHOPEDIATRICS CORP $820.13M $31.41 —
DCTH DELCATH SYSTEMS, INC. $673.84M $19.37 —

News headlines (Yahoo Finance, 1h cache)

Here’s What Drove Stevanato Group’s (STVN) Q3 Outperformance
2026-11-18 16:12 · Yahoo
Stevanato Group to Participate in Upcoming Investor Conferences
2026-11-16 13:00 · Yahoo
Broader Biologics Growth Strengthens Stevanato’s (STVN) Long-Term Outlook
2026-11-10 18:47 · Yahoo
Why Stevanato Group Bears Were Right Before The Drop
2026-11-04 22:10 · Yahoo
Stevanato Group (STVN) Faces Legal Investigation Over GLP 1 Disclosure
2026-11-04 12:15 · Yahoo
Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings
2026-11-04 10:12 · Yahoo
Stevanato Group Q3 Earnings Call Highlights
2026-11-04 09:14 · Yahoo
Stevanato Group S.p.A. Q3 2026 Earnings Call Summary
2026-11-04 03:35 · Yahoo
Stevanato (STVN) Q3 2026 Earnings Call Transcript
2026-11-03 21:17 · Yahoo
Stevanato Group SpA (STVN) (Q3 2026) Earnings Call Highlights: Revenue Climbs 8% as Non-GLP ...
2026-11-03 21:07 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.